Trial Profile
Safety study of Hizentra in patients with Primary Immunodeficiency Disease
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 05 Dec 2015
Price :
$35
*
At a glance
- Drugs Immune globulin (Primary)
- Indications Immunodeficiency disorders
- Focus Adverse reactions; Therapeutic Use
- 05 Dec 2015 New trial record